| 注册
首页|期刊导航|广州医药|糖尿病肾病的重要治疗进展:从基础研究到临床应用

糖尿病肾病的重要治疗进展:从基础研究到临床应用

范李云飞 何凤

广州医药2025,Vol.56Issue(8):1006-1020,1060,16.
广州医药2025,Vol.56Issue(8):1006-1020,1060,16.DOI:10.20223/j.cnki.1000-8535.2025.08.001

糖尿病肾病的重要治疗进展:从基础研究到临床应用

Important advances in diabetic nephropathy treatment:From basic research to clinical application

范李云飞 1何凤1

作者信息

  • 1. 华南理工大学附属第二医院(广州市第一人民医院)肾内科(广东广州 510180)
  • 折叠

摘要

Abstract

Diabetic nephropathy(DN)is a form of chronic kidney disease(CKD)induced by diabetes.Diabetic nephropathy represents the leading cause of CKD and end-stage renal disease both in China and globally.The incidence of DN has been steadily increasing and its prognosis remains unfavorable.Diabetic nephropathy has become a major public health concern.Diabetic nephropathy not only significantly affects patients'quality of life but also increases the risk of cardiovascular diseases.Recent advancements in our understanding of the pathogenesis of DN have facilitated significant progress in treatment options over the past decade.These developments include the introduction of novel pharmacological agents,the implementation of lifestyle modifications,and the exploration of various emerging therapeutic approaches.This review aims to systematically expound the significant therapeutic advancements in the field of DN in recent years,evaluate the efficacy and applicability of these advancements in clinical practice,and explore potential future research directions,thereby providing valuable insights and guidance for clinical practice.

关键词

糖尿病肾病/SGLT-2抑制剂/GLP-1受体激动剂/DPP-4抑制剂/盐皮质激素受体拮抗剂

Key words

diabetic nephropathy/SGLT-2 inhibitors/GLP-1 receptor agonists/DPP-4 inhibitors/mineralocorticoid receptor antagonists

引用本文复制引用

范李云飞,何凤..糖尿病肾病的重要治疗进展:从基础研究到临床应用[J].广州医药,2025,56(8):1006-1020,1060,16.

基金项目

国家自然科学基金(82070752,82470748) (82070752,82470748)

广东省自然科学基金杰出青年基金项目(2022B1515020106) (2022B1515020106)

广东省科技计划项目(202201020273) (202201020273)

广州医药

1000-8535

访问量0
|
下载量0
段落导航相关论文